NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
7.99
Dollar change
+0.01
Percentage change
0.13
%
Index- P/E- EPS (ttm)-2.06 Insider Own32.98% Shs Outstand46.67M Perf Week0.50%
Market Cap381.02M Forward P/E- EPS next Y-1.70 Insider Trans0.00% Shs Float31.96M Perf Month1.01%
Enterprise Value306.61M PEG- EPS next Q-0.42 Inst Own51.23% Short Float0.99% Perf Quarter351.41%
Income-86.73M P/S- EPS this Y11.29% Inst Trans12.93% Short Ratio0.23 Perf Half Y422.22%
Sales0.00M P/B5.73 EPS next Y7.35% ROA-74.69% Short Interest0.32M Perf YTD370.00%
Book/sh1.40 P/C4.37 EPS next 5Y8.10% ROE-102.70% 52W High7.99 0.00% Perf Year82.84%
Cash/sh1.83 P/FCF- EPS past 3/5Y58.15% -19.68% ROIC-113.01% 52W Low1.31 508.99% Perf 3Y187.41%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility0.25% 0.34% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM3.05% Oper. Margin- ATR (14)0.10 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.97 Sales Y/Y TTM- Profit Margin- RSI (14)88.86 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio2.97 EPS Q/Q2.74% SMA200.93% Beta3.35 Target Price8.00
Payout- Debt/Eq0.19 Sales Q/Q- SMA5043.76% Rel Volume0.31 Prev Close7.98
Employees69 LT Debt/Eq0.18 EarningsMay 07 BMO SMA200141.30% Avg Volume1.34M Price7.99
IPOJan 07, 2022 Option/ShortNo / Yes EPS/Sales Surpr.7.58% - Trades Volume421,408 Change0.13%
Date Action Analyst Rating Change Price Target Change
May-28-25Downgrade Stifel Buy → Hold $8
Dec-04-24Initiated William Blair Outperform
Dec-19-23Downgrade Morgan Stanley Equal-Weight → Underweight $13 → $4
Oct-18-23Initiated JMP Securities Mkt Outperform $23
Mar-31-23Initiated Mizuho Buy $15
Sep-16-22Initiated Wedbush Outperform $19
Aug-29-22Initiated H.C. Wainwright Buy $24
Feb-01-22Initiated Stifel Buy $24
Feb-01-22Initiated Morgan Stanley Equal-Weight $17
Feb-01-22Initiated Jefferies Buy $20
Jun-25-25 09:55AM
Jun-09-25 09:55AM
Jun-04-25 07:00AM
Jun-02-25 09:55AM
08:54AM
09:55AM Loading…
May-23-25 09:55AM
May-22-25 07:50PM
12:20PM
11:40AM
10:14AM
10:06AM
08:05AM
07:21AM
May-21-25 08:22PM
07:59PM
07:30PM Loading…
07:30PM
May-07-25 07:00AM
Apr-02-25 07:00AM
Mar-17-25 12:00PM
Mar-13-25 07:00AM
Mar-11-25 07:00AM
Mar-01-25 04:51PM
Jan-30-25 07:00AM
Jan-24-25 06:17AM
Jan-23-25 11:33AM
07:00AM
Jan-08-25 04:05PM
Nov-12-24 07:00AM
Nov-07-24 07:00AM
Nov-05-24 07:00AM
06:52AM Loading…
Sep-18-24 06:52AM
Sep-17-24 07:00AM
Sep-16-24 04:05PM
Aug-29-24 07:00AM
Aug-13-24 07:00AM
Aug-01-24 04:05PM
Jul-30-24 04:05PM
Jul-24-24 03:12PM
07:00AM
Jul-18-24 04:05PM
07:00AM
Jun-29-24 08:26PM
06:30PM
Jun-27-24 08:11AM
07:34AM
02:00AM
Jun-11-24 06:30AM
06:00AM
Jun-05-24 12:55PM
May-30-24 07:05AM
May-28-24 12:00PM
May-08-24 07:40AM
May-07-24 10:55PM
09:08PM
04:05PM
Apr-17-24 04:05PM
Mar-26-24 01:53PM
07:05AM
Mar-20-24 07:05AM
Mar-13-24 07:05AM
Mar-12-24 07:05AM
Mar-06-24 04:25PM
Feb-29-24 04:05PM
Feb-07-24 04:05PM
Jan-03-24 04:30PM
Nov-22-23 04:05PM
Nov-16-23 04:05PM
Nov-07-23 07:05AM
Oct-18-23 09:52AM
Oct-17-23 07:05AM
Oct-05-23 04:01PM
Sep-26-23 07:05AM
Sep-11-23 12:00PM
Sep-08-23 04:05PM
07:05AM
Aug-08-23 07:05AM
Aug-07-23 04:05PM
Jun-01-23 07:00AM
May-10-23 07:00AM
May-09-23 07:00AM
May-08-23 08:30AM
07:08AM
Mar-30-23 07:00AM
Mar-22-23 07:00AM
Mar-21-23 07:00AM
Mar-02-23 04:00PM
Jan-03-23 07:00AM
Dec-15-22 04:01PM
Dec-14-22 04:01PM
Nov-29-22 05:23AM
Nov-28-22 07:00AM
Nov-10-22 07:00AM
Nov-07-22 07:00AM
Nov-02-22 12:43PM
07:00AM
Nov-01-22 07:00AM
Oct-12-22 07:58AM
Sep-14-22 09:55AM
Sep-01-22 07:00AM
Aug-29-22 09:55AM
Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Budd Haeberlein Samantha L.DirectorDec 19 '24Buy1.7112,00020,52012,000Dec 19 06:44 PM
Magovcevic-Liebisch IvanaPresident and CEODec 19 '24Buy1.685,0008,400222,687Dec 19 06:42 PM
Magovcevic-Liebisch IvanaPresident and CEODec 18 '24Buy1.675,0008,350217,687Dec 18 05:51 PM
Magovcevic-Liebisch IvanaPresident and CEODec 05 '24Buy2.345,00011,700212,687Dec 05 05:09 PM
Verni ChristopherFORMER OFFICERSep 19 '24Proposed Sale3.6240,000145,000Sep 19 05:20 PM